Quantitative in vitro phosphor imaging using [3H] and [18F] radioligands:: the effects of chronic desipramine treatment on serotonin 5-HT2 receptors

被引:27
作者
Strome, EM
Jivan, S
Doudet, DJ
机构
[1] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, TRIUMF, PET Grp, Vancouver, BC V6T 2B5, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
antidepressant; autoradiography; ketanserin; PET; receptor binding; setoperone; storage phosphor screen;
D O I
10.1016/j.jneumeth.2004.06.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditionally, autoradiography of neuroreceptors is performed in vitro using tritiated ligands and low sensitivity X-ray film. requiring long exposure times. In vivo imaging of neuroreceptors using positron emission tomography (PET) suffers poor spatial resolution. but in vitro PET autoradiography is difficult with film due to the short half-life of the isotopes. Storage phosphor screens provide an extremely sensitive alternative to film. To demonstrate and validate quantitative in vitro phosphor imaging with PET and tritiated ligands, we treated rats chronically with the antidepressant desipramine, which results in decreased binding to serotonin 5-HT2 receptors. Serotonin 5-HT2 binding decreased significantly in all cortical regions examined as measured by both [H-3]ketanserin and [F-18]setoperone. The data from the two radioligands were not significantly different, and the distribution of the receptors was in agreement with previous reports. We also present data on the reusability of tritium-sensitive phosphor screens, and show that the use of simple corrections allows receptor binding data with PET ligands to be compared across different days. The results indicate that phosphor imaging is a valid. fast., and quantifiable technique for measuring neuroreceptor regulation, and that it provides an excellent tool to corroborate in vivo PET data in vitro at higher resolution. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 154
页数:12
相关论文
共 33 条
  • [1] Adam M. J., 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P258
  • [2] APPEL NM, 1990, J PHARMACOL EXP THER, V255, P843
  • [3] BERGSTROM DA, 1979, J PHARMACOL EXP THER, V209, P256
  • [4] BERGSTROM M, 2004, MOL IMAGING BIOL, V5, P390
  • [5] [11C]S21007, a putative partial agonist for 5-HT3 receptors pet studies.: Rat and primate in vivo biological evaluation.
    Besret, L
    Dauphin, F
    Guillouet, S
    Dhilly, M
    Gourand, F
    Blaizot, X
    Young, AR
    Petit-Taboué, MC
    Mickala, P
    Barbelivien, A
    Rault, S
    Barré, L
    Baron, JC
    [J]. LIFE SCIENCES, 1997, 62 (02) : 115 - 129
  • [6] EFFECTS OF CHRONIC ORAL-ADMINISTRATION OF THE ANTIDEPRESSANTS, DESMETHYLIMIPRAMINE AND ZIMELIDINE ON RAT CORTICAL GABAB BINDING-SITES - A COMPARISON WITH 5-HT2 BINDING-SITE CHANGES
    CROSS, JA
    HORTON, RW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) : 331 - 336
  • [7] FEATURES OF LIGAND-BINDING IN HOMOGENATE AND SECTION PREPARATIONS
    DOHANICH, GP
    HALPAIN, S
    LAMBDIN, LT
    MCEWEN, BS
    [J]. BRAIN RESEARCH, 1986, 366 (1-2) : 338 - 342
  • [8] Synthesis and evaluation of (S)-[18F]-fluoroethylcarazolol for in vivo β-adrenoceptor imaging in the brain
    Doze, P
    van Waarde, A
    Tewson, TJ
    Vaalburg, W
    Elsinga, PH
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2002, 41 (01) : 17 - 27
  • [9] LACK OF EFFECT OF RAPHE LESIONS ON SEROTONIN-S2 RECEPTOR CHANGES INDUCED BY AMITRIPTYLINE AND DESMETHYLIMIPRAMINE
    DUMBRILLEROSS, A
    TANG, SW
    COSCINA, DV
    [J]. PSYCHIATRY RESEARCH, 1982, 7 (02) : 145 - 151
  • [10] In vitro and ex vivo autoradiographic studies of nicotinic acetylcholine receptors using [18F]fluoronorchloroepibatidine in rodent and human brain
    Gatley, SJ
    Ding, YS
    Brady, D
    Gifford, AN
    Dewey, SL
    Carroll, FI
    Fowler, JS
    Volkow, ND
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (05) : 449 - 454